A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

NCT06810934 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: CoTend-BXBB (SARS2-30404)
BIOLOGICAL: CoTend-s3BXBB (SARS2-17032)
BIOLOGICAL: Placebo

Sponsor

Kara Chew

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]